Is it possible to have a psychedelic experience from taking a placebo alone? A new study says it is.
Cortice Biosciences announced today results from placebo-controlled, double-blinded Phase 1 studies evaluating TPI 287, a brain penetrable microtubule stabilizing agent, for the treatment of Alzheimer’s disease, progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS).
A new study argues that clinical improvements reported as being the result of neurofeedback are more likely due to a placebo effect.
According to a new study, lithium appears to be safe and effective in treating bipolar disorder in children, at least in the short term.
A new study reports how well people with depression respond to placebos may determine how well they will respond to antidepressant medications.
According to a new study, even when people are aware they are taking a placebo, they still feel relief from pain.